References 1 Ubukata K, Shibasaki Y, Yamamoto K et al. Association of amino acid substitutions in penicillin-binding protein 3 with b-lactam resistance in b-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother… Click to show full abstract
References 1 Ubukata K, Shibasaki Y, Yamamoto K et al. Association of amino acid substitutions in penicillin-binding protein 3 with b-lactam resistance in b-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001; 45: 1693–9. 2 Seyama S, Wajima T, Nakaminami H et al. Clarithromycin resistance mechanisms of epidemic b-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae strains in Japan. Antimicrob Agents Chemother 2016; 60: 3207–10. 3 Wajima T, Seyama S, Nakamura Y et al. Prevalence of macrolide-nonsusceptible isolates among b-lactamase-negative ampicillin-resistant Haemophilus influenzae in a tertiary care hospital in Japan. J Glob Antimicrob Resist 2016; 6: 22–6. 4 Peric M, Bozdogan B, Jacobs MR et al. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother 2003; 47: 1017–22. 5 Roberts MC, Soge OO, No DB. Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis. J Antimicrob Chemother 2011; 66: 100–4. 6 Atkinson CT, Kunde DA, Tristram SG. Acquired macrolide resistance genes in Haemophilus influenzae? J Antimicrob Chemother 2015; 70: 2234–6. 7 Klugman KP, Lonks JR. Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis 2005; 11: 802–7.
               
Click one of the above tabs to view related content.